All news

Exploring the relationship between Lewy body dementia and delirium

19 April 2021

Lewy body dementia (LBD) is one of the most common forms of dementia. The symptoms of LBD can affect a variety of brain functions including; thinking, attention, sleeping and perception. It is often difficult to diagnose and can appear similar to other medical issues such as delirium. Researchers at the University of Cambridge are looking […]

Study into making financial services dementia-friendly

23 March 2021

Dementia can impair the ability of the individual to manage their financial affairs. This means that they will require support from family members in ensuring good financial outcomes and protection. Often those living with dementia enter into a power of attorney agreement that empowers a named person to act on their behalf and assist them […]

UK COVID-19 research passes one million participants

15 March 2021

More than one million participants have now taken part in COVID-19 research across the UK. We would like to thank all the Join Dementia Research volunteers who have contributed towards this achievement. This milestone has been achieved across England, Northern Ireland, Scotland and Wales by members of the public, NHS doctors and nurses, NIHR research […]

New potential treatment for early-stage Alzheimer’s disease

3 March 2021

Alzheimer’s disease affects approximately 70% of people diagnosed with dementia, and an estimated 26 million people worldwide. In the very early stages, Alzheimer’s disease may be referred to or diagnosed as Mild Cognitive Impairment (MCI). There are no available treatments to prevent or delay the start of Alzheimer’s disease and currently medications only provide a […]

Join us in celebrating 6 years of dementia research

24 February 2021

As we turn six today, we are celebrating not only six years of bringing researchers and volunteers together, but also our collective achievement of helping dementia research to keep going during the pandemic.   See what our volunteers, charity partners and researchers have to say about us!   Since Join Dementia Research began, an incredible […]

How does dementia research translate into practical change?

2 February 2021

The National Institute of Health Research (NIHR)’s Centre for Engagement and Dissemination has this week published a piece of work bringing together NIHR research on several aspects of dementia.  To better understand how research translates into practical change, we asked a number of health and social care professionals, carers and service users to comment on […]

Can remotely delivered real-time health coaching improve cognition?

1 February 2021

Senior man exercising at home

As we get older we tend to spend more time being inactive – up to 60% of older people report sitting for more than four hours per day. The positive impacts of exercise on our physical health are well known, but researchers at Anglia Ruskin University are looking into whether remotely delivered coaching aimed at […]

Adjusting dementia support studies in response to the COVID-19 pandemic

14 January 2021

Man taking part in a zoom meeting

Certain Join Dementia Research studies have adapted to an online offer so that researchers can continue to gain important insights, and ultimately help to support those living with dementia during the COVID-19 pandemic. Beyond the margins Researchers at Durham University, the University of Edinburgh and their partners Innovations in Dementia are developing and testing a […]

Study aims to support independence at home for people with dementia

14 December 2020

home carer helping senior woman get dressed in her bedroom

Most people with dementia want to remain living in their own homes for as long as they can, this can be made possible through either paid or family carers. However, lack of dementia training for paid carers can cause the relationships to break down. For family carers, problems with behaviour and communication can often cause […]

Alzheimer’s drug study restarts

23 November 2020

microscope with lab glassware

An Alzheimer’s drug study is restarting after being paused earlier this year. The CLARITY study is examining whether the drug BAN2401 can be effective in preventing or delaying the very early stages of Alzheimer’s disease.  Alzheimer’s disease affects approximately 26 million people worldwide and current medications only provide a temporary improvement in symptoms. Who can […]